Astellas Pharma Inc.

OTC: ALPMY · Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT

Astellas Pharma Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
74.9B -97.66B 35.91B 37.6B -33.28B 14.51B -1.46B 33.13B -46.13B 48.41B 71.62B 24.81B -8.41B 60.88B 40.92B 30.69B -12.33B 60.08B 22.43B 50.41B
Depreciation & Amortization
47.68B 51.16B 50.02B 50.27B 48.64B 46.98B 38.97B 23.24B 23.02B 23B 22.85B 36.87B 21.08B 21.52B 18.94B 18.14B -18.56B 18.15B 17.94B 18B
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a 14.47B 23.08B 18.28B 14.55B 20.97B -18.99B 64.46B 27.84B -13.77B 19.67B -3.96B -29.45B 21.82B -5.05B 5.25B 42.46B 10.23B -10.56B
Other Non-Cash Items
961M 134.68B -1.24B -49.27B 130.14B 3.2B 4.42B 17.78B 49.29B -7.45B 62.81B 101.92B 71.66B 45.2B 19.1B 82.53B 53.66B 567M 11.41B -19.83B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-22.46B -72.16B -19.87B -26B 22.31B -11.62B -1.85B -60.54B 91.88B 9.43B -16.8B -10.54B 1.31B -22.14B 40.1B -29.95B 28.87B 31.39B 41.58B -26.98B
Operating Cash Flow
101.08B 16.03B 64.81B 12.6B 74.55B 53.08B 40.08B 13.61B 118.07B 73.38B 91.76B 49.12B 48.75B 69.73B 99.46B 40.22B 82.18B 110.18B 93.36B 21.6B
Capital Expenditures
-9.7B 2.29B -15.6B -14B -19.92B -15.27B -30.94B -16.36B -28.12B -20.73B -21.43B -18.26B -17.27B -11.3B -27.96B -19.91B -18.58B -8.96B -6.37B -7.59B
Cash Acquisitions
n/a n/a n/a n/a -190M -24.73B -760.05B n/a n/a n/a n/a n/a 25M 139M 69M -462M 251M -13.2B -40M -1.67B
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a 12.62B 64M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
6.73B -33.02B -782M -25.35B -8.25B -1.97B 16.76B 2.65B -9.7B -7.51B 5.18B -1.17B 2.25B 19.06B -6.92B -846M 1.09B -7.29B -3.55B -19.08B
Investing Cash Flow
-2.96B -30.72B -16.38B -39.35B -24.73B -41.98B -774.23B -13.72B -25.19B -28.18B -16.25B -19.43B -14.99B 7.9B -34.82B -21.22B -14.64B -29.45B -9.96B -28.33B
Debt Repayment
-23.55B -15.57B -16.49B n/a 43.12B -17.23B 511.35B 234B -50B 50B -30B 15B -20B n/a -40B n/a -45B -19B -32B -30B
Common Stock Repurchased
-1M -1M -1M -6.96B -1M -2M -1M -10.73B -50B -2M n/a -10.55B -50B -1M -2M -713M -8.28B -1M -1M -880M
Dividend Paid
n/a -66.23B n/a -62.76B n/a -62.75B n/a -53.9B n/a -54.68B n/a -45.68B n/a -46.32B n/a -38.91B n/a -39.01B n/a -37.15B
Other Financial Acitivies
-67.26B -22.49B -37.85B 50.84B -12.19B -7.04B -6.23B -4.33B -4.5B -5.01B -4.83B -5.37B -5.03B -5B -5.2B -5.1B -4.86B -3.59B -4.76B -4.95B
Financial Cash Flow
-90.81B -104.3B -54.34B -11.92B 30.93B -87.03B 505.12B 165.04B -104.5B -9.69B -34.83B -46.6B -75.03B -51.33B -45.21B -44.73B -58.14B -61.6B -36.76B -72.98B
Net Cash Flow
8.51B 179.87B -302.93B 302.93B 81.71B -80.02B -227.49B 184.65B -4.98B 20.74B 48.06B -2.97B -34.23B 31.92B 16.38B -24.21B 19.61B 19.78B 46.8B -78.46B
Free Cash Flow
91.38B 18.32B 49.21B -1.4B 54.63B 37.81B 9.14B -2.75B 89.95B 52.65B 70.33B 30.86B 31.48B 58.43B 71.5B 20.31B 63.6B 101.22B 86.99B 14.01B